AMY LEE: Open Payments
NPI 1669964912 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 36 payments from 17 companies in 2025. Trend: 2023 $773 · 2024 $616 · 2025 $985
Food & beverage: $910Education: $75
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 5 | $183 |
| Janssen Biotech, Inc. | 5 | $149 |
| ABBVIE INC. | 5 | $131 |
| GENZYME CORPORATION | 2 | $78 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $63 |
| Galderma Laboratories, L.P. | 3 | $48 |
| Boston Scientific Corporation | 1 | $47 |
| Organon LLC | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Amgen Inc. | 2 | $32 |
Products named: Zoryve, TREMFYA, DUPIXENT, SKYRIZI, JUBLIA, RINVOQ, NEMLUVIO, WaveWriter Alpha Prime 16.
Industry payments across GA — which companies pay providers there.
